Andrew Chadeayne, PhD, JD
Andrew Chadeayne brings together expertise in science, entrepreneurship, and patents. Dr. Chadeayne is a PhD chemist, inventor, patent attorney, and founder of multiple profitable companies.
Scientific Expert – Neuroscience and Chemistry
Dr. Chadeayne is an accomplished scientist. He earned BA in chemistry from Princeton University in 2001 and a PhD in chemistry from Cornell University in 2006.
At Princeton, Dr. Chadeayne published work in neuroscience, showing the addictive nature of sugar. See Sugar on the Brain.
At Cornell, he worked with virtually every naturally occurring element on the periodic table, publishing work in organic synthesis, inorganic synthesis, surface science, and materials science. His training under Peter T. Wolczanski left him with a true mastery in the art of breaking problems down to their fundamental mechanisms. As later described by his colleagues in patent law, “Andrew is the guy you call with your hard science questions.”
Dr. Chadeayne has served as an expert witness in chemical cases.
Experienced Innovator and Entrepreneur
Dr. Chadeayne is an inventor on numerous chemical patents, some of which have served as the basis for profitable companies. For example, Dr. Chadeayne is the founder of SwimSpray, LLC, which utilizes his patented vitamin C technology to eliminate swimmers’ longstanding chlorine problems. Dr. Chadeayne tells his story of inventing SwimSpray in the video below:
Experienced Patent Practitioner
Dr. Chadeayne received his law degree from the George Washington University Law School, where he studied patent law under Randall R. Rader, Chief Judge of the Court of Appeals for the Federal Circuit. He was awarded the American Bar Association’s award for excellence in patent law in 2011.
Dr. Chadeayne has 12 years experience as a patent practitioner, working with innovators of all sizes–-ranging from Fortune 500 pharmaceutical companies to independent inventors. He began his career at Finnegan, LLP (a Tier One IP Law Firm), where he was trained in patent prosecution by Charles E. Van Horn. Thereafter, Dr. Chadeayne founded a patent prosecution business, which he ran through 2018.
Recently, Dr. Chadeayne served as Cheif Innovations Officer for ebbu, LLC, where he managed all aspects of designing and building ebbu’s patent portfolio. In October 2018, Ebbu was acquired for more than $400MM in what was described by ebbu’s CEO, Jon Cooper, as “a purely licensing/IP play.” See also Market Watch October 15, 2018, “Canopy Growth to acquire IP and other assets of Colorado-based hemp company Ebbu.”
Presently, Dr. Chadeayne focusses on studying and improving chemical technologies. His practice is divided between (1) developing inventions internally; and (2) consulting for companies within the innovation space.
Dr. Chadeayne’s current research interests include the following:
- Patenting new forms of natural products and processes;
- Gold and gold alloy technology; and
- Early childhood development tools and technology.